Home » En Route to IPO, San Diego’s Prometheus Labs Detours to Nestlé Buyout
En Route to IPO, San Diego’s Prometheus Labs Detours to Nestlé Buyout
San Diego’s , a specialty pharma and diagnostics company in registration for an IPO, has instead agreed to a buyout offer from Nestlé Health Science, a new subsidiary of Switzerland’s Nestlé S.A.
Xconomy
Xconomy
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May